About the CCDPH Perinatal Hepatitis B Prevention Program
The CCDPH Perinatal Hepatitis B Prevention program provides case management and education to pregnant and new mothers who are positive for hepatitis B infection. CCDPH works with hospitals, healthcare providers and laboratories to ensure infants who are exposed to hepatitis B are identified and given timely treatments, vaccinations, and tests to prevent Hepatitis B transmission. Between 2018 and 2022, the CCDPH Perinatal Hepatitis B Prevention Program provided case management for 275 infants exposed to hepatitis B. None of these infants developed hepatitis B infection.
- The public health nurse educates the family and works with the physician before birth, when the positive mother’s hepatitis B status is identified during pregnancy, to reinforce the following steps needed to be taken at and after delivery.
- The infant is given hepatitis B immune globulin (HBIG) within 12 hours of birth and one dose of hepatitis B vaccine.
- This is followed by two additional doses of vaccine at 1 month and 6 months of age.
- Testing for immune response is required to confirm immunity. This is done one to three months after the last dose of hepatitis B vaccine administration, based on vaccine type and schedule.
- IDPH – Perinatal Hepatitis B Program Components
- Perinatal Hepatitis B Program Components 2018 Update
- Perinatal Transmission of Hepatitis B virus
- Hepatitis B and Your Baby
- Give birth to the end of Hep B
- Hepatitis B Vaccine: What You Need to Know
- When a Pregnant Woman Has Hepatitis B
Updated June 30, 2023, 3:56 PM